This may be because the group of determinant CTCs has not been precisely identified, as exemplified by the fact that only vimentin-positive CTCs were related to patient outcomes rather than EpCAM-positive CTCs in colon cancers (22). This evidence concerns the gene EPCAM and colonic neoplasm.